RUXIMLA

Serial Number 86692265
606

Registration Progress

Application Filed
Jul 14, 2015
Under Examination
Jan 19, 2016
Approved for Publication
Nov 24, 2015
Published for Opposition
Nov 24, 2015
Registered

Trademark Image

RUXIMLA

Basic Information

Serial Number
86692265
Filing Date
July 14, 2015
Published for Opposition
November 24, 2015
Abandonment Date
August 22, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 22, 2016
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Katrina Edge

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Aug 22, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 22, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 19, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 24, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 24, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 4, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 16, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 15, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 17, 2015 NWAP I NEW APPLICATION ENTERED Loading...
Jul 17, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005